cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0003234,C1516170,DISRUPTS,Anthracycline Antibiotics,Cancer Cell Growth,antb,neop,1,DISRUPTS_ANTBdrptNEOP
C0011015,C0027651,DISRUPTS,Daunorubicin,Neoplasms,antb,neop,1,DISRUPTS_ANTBdrptNEOP
C0013089,C0027668,DISRUPTS,Doxorubicin,"Neoplasms, Vascular Tissue",antb,neop,1,DISRUPTS_ANTBdrptNEOP
C0013089,C0598934,DISRUPTS,Doxorubicin,tumor growth,antb,neop,3,DISRUPTS_ANTBdrptNEOP
C0013089,C1516170,DISRUPTS,Doxorubicin,Cancer Cell Growth,antb,neop,1,DISRUPTS_ANTBdrptNEOP
C0013089,C2939419,DISRUPTS,Doxorubicin,Secondary Neoplasm,antb,neop,1,DISRUPTS_ANTBdrptNEOP
C0073591,C0597645,DISRUPTS,rosoxacin,Viral Carcinogenesis,antb,neop,1,DISRUPTS_ANTBdrptNEOP
C0073591,C0598934,DISRUPTS,rosoxacin,tumor growth,antb,neop,1,DISRUPTS_ANTBdrptNEOP
